Psoriasis

This cohort study describes and identifies patient characteristics associated with use of in-office narrowband UV-B (NBUVB) or systemic therapy following home NBUVB machine receipt.

This cross-sectional study tests and validates a model explaining the cognitive, behavioral, and disease factors associated with discordant severity grading between physicians and patients with eczema and psoriasis.

This cohort study investigates fertility rates and obstetric outcomes of pregnancies in female patients with psoriasis compared with age- and general practice–matched comparators without psoriasis.

This systematic review of randomized clinical trial and observational study data examines the the effectiveness and safety of biosimilars compared with originator biologics for the treatment of patients with psoriasis.

This randomized clinical trial examines the effect of vitamin D supplementation on psoriasis severity throughout the winter.

This mendelian randomization examines the association between genetically proxied lipid-lowering drugs and psoriasis risk.

This cohort study uses insurance claims data to estimate the 6-month rate of infections among children with psoriasis who started treatment with ustekinumab, etanercept, or methotrexate.

This nonrandomized clinical trial including adults with psoriasis investigates the association of apremilast with aortic vascular inflammation, cardiometabolic function, and adiposity.

This mendelian randomization study investigates the associations between inflammatory bowel disease, particularly Crohn disease and ulcerative colitis, and psoriasis and psoriatic arthritis.

This cohort study assesses generalized pustular psoriasis flares and their treatment, as well as differences between patients with and patients without flares documented in US electronic health records (EHRs).

This cohort study examines the drug survival associated with the effectiveness and safety of commonly used biologics for psoriasis in the UK and Ireland.

This cross-sectional study examines whether a physician’s time spent with a patient with psoriasis differs based on the patient’s race and ethnicity.

This cohort study used predictive modeling and machine learning to examine which biologic therapy for individual patients with psoriasis was associated with treatment retention.